Skip to main
GHK-Cu Prescribed

A hand-set kitchen-table reading of the copper-tripeptide literature — every collagen study, gene-expression map, and hair-follicle trial plated like a family recipe and sourced to the paper it came from.

Study 01

What healed in animals, and what cells did differently

More collagen formed in a 1988 cell experiment. Infected mouse wounds closed sooner in 2025. Those results haven't established better healing for you.

What GHK-Cu cell tests suggest about lung and skin repair

Lung cells from sick patients pulled collagen together better after treatment. Campbell's 2012 experiment examined cells from patients whose lungs had emphysema, a disease damaging the air spaces and making breathing harder. The cells grew outside the patients' bodies. With GHK, their repair work resembled that of healthy lung cells [8]. Scientists also examined 127 genes, instructions in DNA for making proteins. Those genes became more like healthy cells' genes in how actively they were used.

The experiment didn't treat patients or measure whether breathing improved.

Copper helps cells fasten collagen and stretchy fibers together. Protective proteins also use copper, including an enzyme called superoxide dismutase 2, which turns a harmful form of oxygen into hydrogen peroxide. Copper's repair jobs explain the interest in GHK-Cu, but watching a cell use copper outside the body hasn't established healing in patients or easier breathing for a person trying to manage lung disease in daily life.

Other experiments found more skin-cell growth and collagen [1][2]. Retinol, an ingredient in skin products, helps replace older skin cells [7]. GHK-Cu instead affects collagen repair and the use of protein-making instructions. Researchers have proposed combining the two, without testing whether that improves people's skin.

A reason to try an experiment isn't an established treatment benefit.

In another dish test, GHK-Cu reached 10 micromolar, a lab measure for little GHK-Cu in liquid, though more than in early collagen tests [12]. Micromolar counts tiny pieces of GHK-Cu mixed into the liquid. Treated skin cells changed shape and made more proteins linked with growth. The change suggested continued cell growth, without measuring wrinkles or wound closure.

How GHK-Cu raised collagen production in cells and rats

Maquart's 1988 experiment found that treated human cells produced extra collagen [1]. Collagen gives skin strength and helps skin resist pulling. The cells lived in dishes, and researchers counted them separately. Extra collagen couldn't be explained simply by having more cells. Larger amounts of GHK-Cu brought larger increases.

The collagen finding still needs a human test of wound healing.

A 1993 experiment measured new tissue below wounded rats' skin. More GHK-Cu brought more tissue at the healing sites. Collagen, other proteins, and DNA all increased [2]. DNA holds the instructions a cell uses to do its work. Substances that hold water around cells increased as well. The rise in collagen was twice the rise in other wound proteins. That compares the two increases; it doesn't mean collagen doubled from its starting amount.

The rats' healed skin wasn't tested for strength against pulling.

Copper may help join the new collagen strands [3]. In another cell experiment, the treated cells released less protein associated with raised scars [13]. Researchers used GHK-Cu at 1 nanomolar, a trace in liquid, weaker than the micromolar mixture in the skin-cell growth test.

A weaker lab mixture can affect cells without establishing a treatment amount.

These experiments explain the interest in repair [1][2]. Before extra collagen tells you about useful repair, human trials need to check stronger healed tissue, smaller scars and possible harm after treatment.

How GHK-Cu raised collagen production in cells and rats

What GHK-Cu gel helped close in infected mouse wounds

GHK-Cu gel sped closure of infected mouse wounds in 2025. By day 12, over 95% of treated wound area had closed. The comparison mice reached about 65% [18]. The treated wound sites grew new blood vessels and produced extra collagen. The gel also fought both kinds of bacteria used. The mice also made fewer chemicals that drive inflammation, which can bring swelling after injury.

These mice don't tell you whether the gel helps human wounds.

Pickart's 2015 review described quicker healing across rats, mice, rabbits, pigs and dogs [4]. Tests examined skin, hair roots, gut tissue, bone and foot pads. Some treated animals grew new blood vessels more readily. Others gained more defense against chemicals that damage tissue. Rats and mice sometimes had repair changes beyond the treated wound.

Researchers haven't shown the same whole-body benefit in people.

A 2018 review reported a 9-fold rise in collagen at rat wounds [22]. These rats had no other illness. The collagen amount didn't measure how strong the wound became. In diabetic animals, dressings with GHK and collagen helped new skin cover wounds sooner. Protective substances increased too.

Quicker closure and extra tissue still need human tests.

Tests involving people have mainly examined creams and similar products. Published trials haven't tested GHK-Cu injections for human wound healing [4][18][22]. Before a result can guide your wound care, researchers need to check whether people heal better, whether healed skin stays strong, and whether treatment brings harm.

What GHK-Cu gene counts tell you about cell activity

A computer comparison found changes in how actively cells used 4,000 genes. Genes are instructions in DNA for making proteins. Pickart and Margolina described the comparison in 2018 [3]. Nobody received treatment in a health trial.

Your strength, healing and memory weren't measured.

The report linked GHK-Cu with changed activity in over 4,000 human genes. Cells make messages from genes to tell the cell which proteins to produce. Researchers counted those messages. The measured changes were at least 50% above or below activity in cells without treatment. Among the genes that changed, 59% became more active and 41% less active.

More activity isn't always good, and less isn't always bad.

Some genes help cells clear damaged proteins. In that group, activity rose for 41 genes and fell for 1. Another group contained 408 genes linked with nerve work. Activity fell for 230 of those genes. That count couldn't tell whether a nerve gained help or lost something useful.

No test measured better nerve function from those changes.

Pickart's 2018 report compared gene activity with younger tissue [3]. Treated cells used some protein-making instructions more like younger tissue did. The comparison didn't measure anyone becoming younger. The 4,000-gene count describes lab findings examined by computer, without measuring whether a treated person healed sooner, gained strength, remembered more clearly or had other changes that mattered in daily life.

Trials need to check benefits you can notice and harms you might face.

What GHK-Cu reduced after injury to mice's lungs

Treated mice made fewer chemicals that drive inflammation after lung injury. Inflammation is the body's response to injury and can cause swelling. Park's 2016 test gave each mouse a belly shot [5]. The amount matched the mouse's weight: either 1 or 10 micrograms of GHK-Cu per gram of a mouse's weight. Micrograms weigh millionths of a gram. Treated cells also gained defenses against harmful chemicals.

Researchers didn't test relief of breathing trouble in people.

Other animal tests found related changes. A comparison between treated and untreated people has not shown less inflammation throughout the body after GHK-Cu [5][15]. Your symptoms weren't measured in these animal experiments.

In 2022, mice exposed to smoke received belly shots for 12 weeks [15]. Daily amounts included 2 and 20 micrograms of GHK-Cu per gram of a mouse's weight. Damage to small lung air spaces decreased. In a separate dish experiment, human lung cells released fewer injury-related chemicals and resisted chemical damage better.

Cells outside a body can't show whether a patient breathes better.

Another mouse experiment used a drug to cause lung scars [6]. GHK reduced scarring at all three amounts tested. The paper lists 26 and 260 micrograms per milliliter, strengths that describe the GHK amount in a small measure of liquid. The paper adds “per day” without clearly stating the total in each mouse's shot.

Human breathing benefits remain untested.

What GHK-Cu reduced after injury to mice's lungs

What GHK-Cu lung and cancer comparisons leave unproved

Human lung cells did repair work more like healthy cells after GHK. Campbell's 2012 experiment treated cells outside the bodies of patients with emphysema [8]. Emphysema damages the lungs' small air spaces. Activity in 127 genes, instructions for making proteins, also shifted toward healthy-cell activity.

By 2026, no human trial had tested that lung benefit [8][15].

A computer comparison ranked GHK-Cu first among 1,309 substances for possibly undoing disease-linked changes in gene activity [10]. Lung disease and spreading colon cancer were separate comparisons. Each asked whether a substance could shift that illness's cell activity toward normal.

Nobody tested better breathing or shrinking cancer in that comparison.

A separate dish experiment used GHK-Cu at 1 micromolar, a small amount in liquid, though more than in the nanomolar mixtures in early collagen tests [10]. Of 54 genes unusually active in aggressive colon cancer, 70% became less active. Cells made fewer messages from those genes to direct protein production. The instructions stored in the genes hadn't changed.

You can't infer a cancer treatment from this cell finding.

What improved in mice's memory after GHK-Cu nose treatment

Older mice found maze routes more readily after treatment through the nose. Tucker's two 2023 reports tested GHK-Cu in aging mice and mice with Alzheimer's-like disease. The reports were early drafts, which means scientists outside the authors' teams hadn't finished checking how the mouse experiments were done or whether the findings supported the claims being made.

Early mouse findings may change when other scientists examine the methods.

The old mice received daily nose treatment for 8 weeks [19]. Researchers used 15 milligrams of GHK-Cu per kilogram of mouse weight. The amount increased with the mouse's weight. Males and females both improved at finding routes and escaping a box maze. Brain tests suggested less nerve damage and fewer chemicals involved in inflammation.

These tests haven't established better memory for you.

Mice with Alzheimer's-like disease received that amount 3 times weekly for 12 weeks [17]. Their brains had fewer protein clumps, and maze performance improved. Pickart's 2018 review also reported more nerve-growth proteins in dishes [9]. Injured nerves grew back sooner in some rat and mouse tests.

Min's 2024 experiment examined GHK without copper attached [20]. Nerve cells and cells supporting nerves survived copper and zinc damage better. The cells were grown in a lab. Treatment limited harmful protein clumps and chemical reactions caused by the metals.

People still need trials measuring memory and everyday abilities.